Literature DB >> 16408018

High-throughput assays for promiscuous inhibitors.

Brian Y Feng1, Anang Shelat, Thompson N Doman, R Kip Guy, Brian K Shoichet.   

Abstract

High-throughput screening (HTS) searches large libraries of chemical compounds for those that can modulate the activity of a particular biological target; it is the dominant technique used in early-stage drug discovery. A key problem in HTS is the prevalence of nonspecific or 'promiscuous' inhibitors. These molecules have peculiar properties, act on unrelated targets and can dominate the results from screening campaigns. Several explanations have been proposed to account for promiscuous inhibitors, including chemical reactivity, interference in assay read-out, high molecular flexibility and hydrophobicity. The diversity of these models reflects the apparently unrelated molecules whose behaviors they seek to explain. However, a single mechanism may explain the effects of many promiscuous inhibitors: some organic molecules form large colloid-like aggregates that sequester and thereby inhibit enzymes. Hits from HTS, leads for drug discovery and even several drugs appear to act through this mechanism at micromolar concentrations. Here, we report two rapid assays for detecting promiscuous aggregates that we tested against 1,030 'drug-like' molecules. The results from these assays were used to test two preliminary computational models of this phenomenon and as benchmarks to develop new models.

Mesh:

Substances:

Year:  2005        PMID: 16408018     DOI: 10.1038/nchembio718

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  114 in total

1.  Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.

Authors:  Erin M Bowers; Gai Yan; Chandrani Mukherjee; Andrew Orry; Ling Wang; Marc A Holbert; Nicholas T Crump; Catherine A Hazzalin; Glen Liszczak; Hua Yuan; Cecilia Larocca; S Adrian Saldanha; Ruben Abagyan; Yan Sun; David J Meyers; Ronen Marmorstein; Louis C Mahadevan; Rhoda M Alani; Philip A Cole
Journal:  Chem Biol       Date:  2010-05-28

2.  A novel class of small molecule inhibitors of HDAC6.

Authors:  Elizabeth S Inks; Benjamin J Josey; Sean R Jesinkey; C James Chou
Journal:  ACS Chem Biol       Date:  2011-11-11       Impact factor: 5.100

3.  Use of allostery to identify inhibitors of calmodulin-induced activation of Bacillus anthracis edema factor.

Authors:  Elodie Laine; Christophe Goncalves; Johanna C Karst; Aurélien Lesnard; Sylvain Rault; Wei-Jen Tang; Thérèse E Malliavin; Daniel Ladant; Arnaud Blondel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

Review 4.  PubChem as a public resource for drug discovery.

Authors:  Qingliang Li; Tiejun Cheng; Yanli Wang; Stephen H Bryant
Journal:  Drug Discov Today       Date:  2010-10-21       Impact factor: 7.851

5.  Identification of broad-based HIV-1 protease inhibitors from combinatorial libraries.

Authors:  Max W Chang; Michael J Giffin; Rolf Muller; Jeremiah Savage; Ying C Lin; Sukwon Hong; Wei Jin; Landon R Whitby; John H Elder; Dale L Boger; Bruce E Torbett
Journal:  Biochem J       Date:  2010-08-01       Impact factor: 3.857

6.  Identification and Characterization of Novel Broad-Spectrum Inhibitors of the Flavivirus Methyltransferase.

Authors:  Matthew Brecher; Hui Chen; Zhong Li; Nilesh K Banavali; Susan A Jones; Jing Zhang; Laura D Kramer; Hongmin Li
Journal:  ACS Infect Dis       Date:  2015-07-31       Impact factor: 5.084

7.  Different Inhibitors of Aβ42-Induced Toxicity Have Distinct Metal-Ion Dependency.

Authors:  Ashley J Mason; Ian Hurst; Ravinder Malik; Ibrar Siddique; Inna Solomonov; Irit Sagi; Frank-Gerrit Klärner; Thomas Schrader; Gal Bitan
Journal:  ACS Chem Neurosci       Date:  2020-07-07       Impact factor: 4.418

8.  Discovery of a novel inhibitor of NAD(P)(+)-dependent malic enzyme (ME2) by high-throughput screening.

Authors:  Yi Wen; Lei Xu; Fang-lei Chen; Jing Gao; Jing-ya Li; Li-hong Hu; Jia Li
Journal:  Acta Pharmacol Sin       Date:  2014-03-31       Impact factor: 6.150

9.  High-throughput screening AlphaScreen assay for identification of small-molecule inhibitors of ubiquitin E3 ligase SCFSkp2-Cks1.

Authors:  Dana Ungermannova; Junglim Lee; Gan Zhang; H Garry Dallmann; Charles S McHenry; Xuedong Liu
Journal:  J Biomol Screen       Date:  2013-04-15

10.  Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease.

Authors:  Ajit Jadhav; Rafaela S Ferreira; Carleen Klumpp; Bryan T Mott; Christopher P Austin; James Inglese; Craig J Thomas; David J Maloney; Brian K Shoichet; Anton Simeonov
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.